During the past decade, Carolina Urologic Research Center conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 57 clinical trials were completed, i.e. on average, 67.9% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 21 clinical trials were completed. i.e. 45.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Urologic Research Center" #1 sponsor was "Ferring Pharmaceuticals" with 11 trials, followed by "Pfizer" with 10 trials sponsored, "Janssen Research & Development, LLC" with 9 trials sponsored, "Dendreon" with 6 trials sponsored and "Bayer" with 6 trials sponsored. Other sponsors include 109 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Urologic Research Center" #1 collaborator was "Astellas Pharma Inc" with 7 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 4 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Carolina Urologic Research Center" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Urologic Research Center" are "Prostate Cancer" (37 trials), "Prostatic Neoplasms" (11 trials), "Bladder Cancer" (9 trials), "Benign Prostatic Hyperplasia" (6 trials) and "Prostate Cancer Metastatic" (5 trials). Many other conditions were trialed in "Carolina Urologic Research Center" in a lesser frequency.

Most popular intervention types in "Carolina Urologic Research Center" are "Drug" (113 trials), "Biological" (23 trials), "Device" (14 trials), "Other" (14 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Enzalutamide" (13 trials), "Prednisone" (8 trials), "Abiraterone" (4 trials) and "Apalutamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Urologic Research Center" are 101 trials for "Male" genders, 46 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Carolina Urologic Research Center". undefined are not yet recruiting, 21 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Carolina Urologic Research Center, 2 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Urologic Research Center, 29 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 12 trials that are defined as “Not Applicable".